Cargando…

Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes

Secondary prevention therapy reduces death and reinfarction after acute myocardial infarction (AMI), but it is underutilized in clinical practice. Mechanisms for this therapeutic gap are not well established. In this study, we have explored and evaluated the impact of passive continuation compared t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xurui Huang, Nancy, Sanderson, John E., Fang, Fang, Yu, Cheuk-Man, Yan, Bryan P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718309/
https://www.ncbi.nlm.nih.gov/pubmed/34976331
http://dx.doi.org/10.1155/2021/9543912
_version_ 1784624695648190464
author Xurui Huang, Nancy
Sanderson, John E.
Fang, Fang
Yu, Cheuk-Man
Yan, Bryan P.
author_facet Xurui Huang, Nancy
Sanderson, John E.
Fang, Fang
Yu, Cheuk-Man
Yan, Bryan P.
author_sort Xurui Huang, Nancy
collection PubMed
description Secondary prevention therapy reduces death and reinfarction after acute myocardial infarction (AMI), but it is underutilized in clinical practice. Mechanisms for this therapeutic gap are not well established. In this study, we have explored and evaluated the impact of passive continuation compared to active initiation of secondary prevention therapy for AMI during the index hospitalization. For this purpose, we have analyzed 1083 consecutive patients with AMI to a tertiary referral hospital in Hong Kong and assessed discharge prescription rates of secondary prevention therapies (aspirin, beta-blockers, statins, and ACEI/ARBs). Multivariate analysis was used to identify independent predictors of discharge medication, and Kaplan–Meier survival curve was used to evaluate 12-month survival. Overall, prescription rates of aspirin, beta-blocker, statin, and ACEI/ARBs on discharge were 94.8%, 64.5%, 83.5%, and 61.4%, respectively. Multivariate analysis showed that prior use of each therapy was an independent predictor of prescription of the same therapy on discharge: aspirin (odds ratio (OR) = 4.8, 95% CI = 1.9–12.3, P < 0.01), beta-blocker (OR = 2.5, 95% CI = 1.8–3.4, P < 0.01); statin (OR = 8.3, 95% CI = 0.4–15.7, P < 0.01), and ACEI/ARBs (OR = 2.9, 95% CI = 2.0–4.3, P < 0.01). Passive continuation of prior medication was associated with higher 1-year mortality rates than active initiation in treatment-naïve patients (aspirin (13.7% vs. 5.7%), beta-blockers (12.9% vs. 5.6%), and statins (11.0% vs. 4.6%); all P < 0.01). Overall, the use of secondary prevention medication for AMI was suboptimal. Our findings suggested that the practice of passive continuation of prior medication was prevalent and associated with adverse clinical outcomes compared to active initiation of secondary preventive therapies for acute myocardial infarction during the index hospitalization.
format Online
Article
Text
id pubmed-8718309
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87183092021-12-31 Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes Xurui Huang, Nancy Sanderson, John E. Fang, Fang Yu, Cheuk-Man Yan, Bryan P. J Healthc Eng Research Article Secondary prevention therapy reduces death and reinfarction after acute myocardial infarction (AMI), but it is underutilized in clinical practice. Mechanisms for this therapeutic gap are not well established. In this study, we have explored and evaluated the impact of passive continuation compared to active initiation of secondary prevention therapy for AMI during the index hospitalization. For this purpose, we have analyzed 1083 consecutive patients with AMI to a tertiary referral hospital in Hong Kong and assessed discharge prescription rates of secondary prevention therapies (aspirin, beta-blockers, statins, and ACEI/ARBs). Multivariate analysis was used to identify independent predictors of discharge medication, and Kaplan–Meier survival curve was used to evaluate 12-month survival. Overall, prescription rates of aspirin, beta-blocker, statin, and ACEI/ARBs on discharge were 94.8%, 64.5%, 83.5%, and 61.4%, respectively. Multivariate analysis showed that prior use of each therapy was an independent predictor of prescription of the same therapy on discharge: aspirin (odds ratio (OR) = 4.8, 95% CI = 1.9–12.3, P < 0.01), beta-blocker (OR = 2.5, 95% CI = 1.8–3.4, P < 0.01); statin (OR = 8.3, 95% CI = 0.4–15.7, P < 0.01), and ACEI/ARBs (OR = 2.9, 95% CI = 2.0–4.3, P < 0.01). Passive continuation of prior medication was associated with higher 1-year mortality rates than active initiation in treatment-naïve patients (aspirin (13.7% vs. 5.7%), beta-blockers (12.9% vs. 5.6%), and statins (11.0% vs. 4.6%); all P < 0.01). Overall, the use of secondary prevention medication for AMI was suboptimal. Our findings suggested that the practice of passive continuation of prior medication was prevalent and associated with adverse clinical outcomes compared to active initiation of secondary preventive therapies for acute myocardial infarction during the index hospitalization. Hindawi 2021-12-23 /pmc/articles/PMC8718309/ /pubmed/34976331 http://dx.doi.org/10.1155/2021/9543912 Text en Copyright © 2021 Nancy Xurui Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Xurui Huang, Nancy
Sanderson, John E.
Fang, Fang
Yu, Cheuk-Man
Yan, Bryan P.
Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes
title Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes
title_full Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes
title_fullStr Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes
title_full_unstemmed Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes
title_short Passive Prescription of Secondary Prevention Medical Therapy during Index Hospitalization for Acute Myocardial Infarction Is Prevalent and Associated with Adverse Clinical Outcomes
title_sort passive prescription of secondary prevention medical therapy during index hospitalization for acute myocardial infarction is prevalent and associated with adverse clinical outcomes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718309/
https://www.ncbi.nlm.nih.gov/pubmed/34976331
http://dx.doi.org/10.1155/2021/9543912
work_keys_str_mv AT xuruihuangnancy passiveprescriptionofsecondarypreventionmedicaltherapyduringindexhospitalizationforacutemyocardialinfarctionisprevalentandassociatedwithadverseclinicaloutcomes
AT sandersonjohne passiveprescriptionofsecondarypreventionmedicaltherapyduringindexhospitalizationforacutemyocardialinfarctionisprevalentandassociatedwithadverseclinicaloutcomes
AT fangfang passiveprescriptionofsecondarypreventionmedicaltherapyduringindexhospitalizationforacutemyocardialinfarctionisprevalentandassociatedwithadverseclinicaloutcomes
AT yucheukman passiveprescriptionofsecondarypreventionmedicaltherapyduringindexhospitalizationforacutemyocardialinfarctionisprevalentandassociatedwithadverseclinicaloutcomes
AT yanbryanp passiveprescriptionofsecondarypreventionmedicaltherapyduringindexhospitalizationforacutemyocardialinfarctionisprevalentandassociatedwithadverseclinicaloutcomes